1126698

AACE Pharmaceuticals, Inc. — FEI 3013433273

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 10, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
240121 CFR 211.194(a)(4)Complete Test Data
344521 CFR 211.65(a)Equipment construction - reactive surfaces